Literature DB >> 15848745

A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma.

Christine M Lohse1, John C Cheville.   

Abstract

Accurate subtyping of RCC is critically important and should be considered in algorithms that are developed as prognostic tools for the patient and clinician. The TNM classification, already a powerful prognostic factor, will continue to evolve. The authors recommend that each component of the classification be assessed and reported during pathologic examination. This article also highlighted the importance of assigning a nuclear grade that is based on standardized and reproducible criteria that reflect the heterogeneity of nuclear and nucleolar features within RCC. Lastly, it is increasingly evident that coagulative tumor necrosis and sarcomatoid differentiation are compelling prognostic factors, on par with nuclear grade, and should be assessed routinely. To conclude, the complete list of pathologic features that are evaluated as part of the Mayo Clinic Nephrectomy Registry is presented. The features that are reported routinely in clinical practice also are indicated; this can serve as a guide for the reporting of results from the pathologic examination of RCC.

Entities:  

Mesh:

Year:  2005        PMID: 15848745     DOI: 10.1016/j.cll.2005.01.013

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  17 in total

1.  A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.

Authors:  Inkeun Park; Hyo Jin Lee; Woo Kyoon Bae; Shinkyo Yoon; Jae Lyun Lee
Journal:  Invest New Drugs       Date:  2019-06-24       Impact factor: 3.850

2.  Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: a report of three cases.

Authors:  Maria Carmen Areses; Urbano Anido Herranz; Beatriz Bernárdez Ferrán; Luis León Mateos; Jorge Garcia González; Rafael López López
Journal:  Med Oncol       Date:  2011-05-11       Impact factor: 3.064

3.  Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma.

Authors:  Michele Avissar-Whiting; Devin C Koestler; E Andres Houseman; Brock C Christensen; Karl T Kelsey; Carmen J Marsit
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

4.  Clinicopathological characteristics and cell cycle proteins as potential prognostic factors in myoepithelial carcinoma of salivary glands.

Authors:  F Passador-Santos; M Grönroos; J Irish; R Gilbert; P Gullane; B Perez-Ordonez; A Mäkitie; I Leivo
Journal:  Virchows Arch       Date:  2015-12-28       Impact factor: 4.064

Review 5.  Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.

Authors:  Giovanni M Frascà; Fabiana Brigante; Alessandro Volpe; Laura Cosmai; Maurizio Gallieni; Camillo Porta
Journal:  J Nephrol       Date:  2018-10-16       Impact factor: 3.902

6.  Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma.

Authors:  Brant A Inman; Xavier Frigola; Kimberley J Harris; Susan M Kuntz; Christine M Lohse; Bradley C Leibovich; Eugene D Kwon
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

7.  Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.

Authors:  Wesam M Osman; Nermeen S Youssef
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 8.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

9.  Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas.

Authors:  Zhong Jiang; Christine M Lohse; Peigou G Chu; Chin-Lee Wu; Bruce A Woda; Kenneth L Rock; Eugene D Kwon
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

10.  Spontaneous regression of metastatic pulmonary renal cell carcinoma in the setting of sarcomatoid differentiation of the primary tumour.

Authors:  Brian P H Chan; Christopher M Booth; Marosh Manduch; Naji J Touma
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.